Table of Contents Author Guidelines Submit a Manuscript
Journal of Nutrition and Metabolism
Volume 2017, Article ID 4297025, 14 pages
https://doi.org/10.1155/2017/4297025
Research Article

Diet-Induced Obesity Is Associated with an Impaired NK Cell Function and an Increased Colon Cancer Incidence

1Institute of Anatomy and Cell Biology, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
2Institute of Pathology, University Hospital of Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
3Clinic for Internal Medicine IV, Department of Hematology and Oncology, University Hospital of Martin Luther University Halle-Wittenberg, Halle (Saale), Germany

Correspondence should be addressed to Ina Bähr; ed.ellah-inu.nizidem@rheab.ani

Received 7 October 2016; Revised 6 February 2017; Accepted 15 February 2017; Published 5 March 2017

Academic Editor: Phillip B. Hylemon

Copyright © 2017 Ina Bähr et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Obesity and Overweight, WHO fact sheet N 311, World Health Organisation, Geneva, Switzerland, 2015.
  2. M. Dobbins, K. Decorby, and B. C. Choi, “The Association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011,” ISRN Preventive Medicine, vol. 2013, Article ID 680536, 16 pages, 2013. View at Publisher · View at Google Scholar
  3. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, “Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1625–1638, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Y. Wolin, K. Carson, and G. A. Colditz, “Obesity and cancer,” Oncologist, vol. 15, no. 6, pp. 556–565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. O. Alemán, L. H. Eusebi, L. Ricciardiello, K. Patidar, A. J. Sanyal, and P. R. Holt, “Mechanisms of obesity-induced gastrointestinal neoplasia,” Gastroenterology, vol. 146, no. 2, pp. 357–373, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Keum, D. C. Greenwood, D. H. O. Lee et al., “Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies,” Journal of the National Cancer Institute, vol. 107, no. 3, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. S. C. Larsson and A. Wolk, “Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies,” The American Journal of Clinical Nutrition, vol. 86, no. 3, pp. 556–565, 2007. View at Google Scholar · View at Scopus
  8. P. T. Campbell, C. C. Newton, A. N. Dehal, E. J. Jacobs, A. V. Patel, and S. M. Gapstur, “Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort,” Journal of Clinical Oncology, vol. 30, no. 1, pp. 42–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Bardou, A. N. Barkun, and M. Martel, “Obesity and colorectal cancer,” Gut, vol. 62, no. 6, pp. 933–947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Nistal, N. Fernández-Fernández, S. Vivas, and J. L. Olcoz, “Factors determining colorectal cancer: the role of the intestinal microbiota,” Frontiers in Oncology, vol. 5, article 220, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. C. A. Stewart, E. Vivier, and M. Colonna, “Strategies of natural killer cell recognition and signaling,” Current Topics in Microbiology and Immunology, vol. 298, pp. 1–21, 2006. View at Google Scholar
  12. P. Yaqoob, E. A. Newsholme, and P. C. Calder, “Inhibition of natural killer cell activity by dietary lipids,” Immunology Letters, vol. 41, no. 2-3, pp. 241–247, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. N. M. Jeffery, P. Sanderson, E. A. Newsholme, and P. C. Calder, “Effects of varying the type of saturated fatty acid in the rat diet upon serum lipid levels and spleen lymphocyte functions,” Biochimica et Biophysica Acta (BBA)—Lipids and Lipid Metabolism, vol. 1345, no. 3, pp. 223–236, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. A. G. Smith, P. A. Sheridan, J. B. Harp, and M. A. Beck, “Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus,” Journal of Nutrition, vol. 137, no. 5, pp. 1236–1243, 2007. View at Google Scholar · View at Scopus
  15. H. Nave, G. Mueller, B. Siegmund et al., “Resistance of Janus kinase-2 dependent leptin signaling in natural killer (NK) Cells: a novel mechanism of NK cell dysfunction in diet-induced obesity,” Endocrinology, vol. 149, no. 7, pp. 3370–3378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. O'Shea, T. J. Cawood, C. O'Farrelly, and L. Lynch, “Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke,” PLOS ONE, vol. 5, no. 1, Article ID e8660, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Viel, L. Besson, E. Charrier et al., “Alteration of Natural Killer cell phenotype and function in obese individuals,” Clinical Immunology, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Laue, C. D. Wrann, B. Hoffmann-Castendiek, D. Pietsch, L. Hübner, and H. Kielstein, “Altered NK cell function in obese healthy humans,” BMC Obesity, vol. 2, article 1, 2015. View at Publisher · View at Google Scholar
  19. A. Lautenbach, C. D. Wrann, R. Jacobs, G. Müller, G. Brabant, and H. Nave, “Altered phenotype of NK cells from obese rats can be normalized by transfer into lean animals,” Obesity, vol. 17, no. 10, pp. 1848–1855, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. M. Moulin, I. Marguti, J. P. S. Peron, A. Halpern, and L. V. Rizzo, “Bariatric surgery reverses natural killer (NK) cell activity and NK-related cytokine synthesis impairment induced by morbid obesity,” Obesity Surgery, vol. 21, no. 1, pp. 112–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Jahn, M. Spielau, C. Brandsch et al., “Decreased NK cell functions in obesity can be reactivated by fat mass reduction,” Obesity, vol. 23, no. 11, pp. 2233–2241, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. N. R. Shah and E. R. Braverman, “Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin,” PLoS ONE, vol. 7, no. 4, Article ID e33308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. R. V. Considine and J. F. Caro, “Leptin in humans: current progress and future directions,” Clinical Chemistry, vol. 42, no. 6, part 1, pp. 843–844, 1996. View at Google Scholar · View at Scopus
  24. C. D. Wrann, T. Laue, L. Hübner et al., “Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions,” American Journal of Physiology - Endocrinology and Metabolism, vol. 302, no. 1, pp. E108–E116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT-PCR,” Nucleic Acids Research, vol. 29, no. 9, article e45, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Basen-Engquist and M. Chang, “Obesity and cancer risk: recent review and evidence,” Current Oncology Reports, vol. 13, no. 1, pp. 71–76, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. V. A. Gerriets and N. J. MacIver, “Role of T cells in malnutrition and obesity,” Frontiers in Immunology, vol. 5, article 379, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Zhao, R. Sun, L. You, C. Gao, and Z. Tian, “Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines,” Biochemical and Biophysical Research Communications, vol. 300, no. 2, pp. 247–252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Tian, R. Sun, H. Wei, and B. Gao, “Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation,” Biochemical and Biophysical Research Communications, vol. 298, no. 3, pp. 297–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Lamas, N. Goncalves-Mendes, R. Nachat-Kappes et al., “Leptin modulates dose-dependently the metabolic and cytolytic activities of NK-92 cells,” Journal of Cellular Physiology, vol. 228, no. 6, pp. 1202–1209, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J.-H. Gong, G. Maki, and H.-G. Klingemann, “Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells,” Leukemia, vol. 8, no. 4, pp. 652–658, 1994. View at Google Scholar · View at Scopus
  32. H. Klingemann, L. Boissel, and F. Toneguzzo, “Natural killer cells for immunotherapy—advantages of the NK-92 cell line over blood NK cells,” Frontiers in Immunology, vol. 7, article 91, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Wilk, A. Jenke, J. Stehr et al., “Adiponectin modulates NK-cell function,” European Journal of Immunology, vol. 43, no. 4, pp. 1024–1033, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. K.-Y. Kim, J. K. Kim, S. H. Han et al., “Adiponectin is a negative regulator of NK cell cytotoxicity,” The Journal of Immunology, vol. 176, no. 10, pp. 5958–5964, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Ni, R. Sun, B. Fu et al., “IGF-1 promotes the development and cytotoxic activity of human NK cells,” Nature Communications, vol. 4, article 1479, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Lucas, S. J. Parikh, S. Sridhar et al., “Cytokine profiling of young overweight and obese female African American adults with prediabetes,” Cytokine, vol. 64, no. 1, pp. 310–315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Dandona, R. Weinstock, K. Thusu, E. Abdel-Rahman, A. Aljada, and T. Wadden, “Tumor necrosis factor-α in sera of obese patients: fall with weight loss,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 8, pp. 2907–2910, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. A. A. Cooke, R. M. Connaughton, C. L. Lyons, A. M. McMorrow, and H. M. Roche, “Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome,” European Journal of Pharmacology, vol. 785, pp. 207–214, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Elkabets, V. S. G. Ribeiro, C. A. Dinarello et al., “IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function,” European Journal of Immunology, vol. 40, no. 12, pp. 3347–3357, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Ambrosini, F. Loiacono, R. Conte et al., “IL-1beta inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors,” European Journal of Immunology, vol. 45, no. 7, pp. 2061–2071, 2015. View at Publisher · View at Google Scholar
  41. F. N. Lauw, D. Pajkrt, C. E. Hack, M. Kurimoto, S. J. H. Van Deventer, and T. Van der Poll, “Proinflammatory effects of IL-10 during human endotoxemia,” The Journal of Immunology, vol. 165, no. 5, pp. 2783–2789, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Cai, R. A. Kastelein, and C. A. Hunter, “IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18,” European Journal of Immunology, vol. 29, no. 9, pp. 2658–2665, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. S.-I. Tanaka, F. Isoda, Y. Ishihara, M. Kimura, and T. Yamakawa, “T lymphopaenia in relation to body mass index and TNF-α in human obesity: adequate weight reduction can be corrective,” Clinical Endocrinology, vol. 54, no. 3, pp. 347–354, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. R. W. O'Rourke, T. Kay, M. H. Scholz et al., “Alterations in T-cell subset frequency in peripheral blood in obesity,” Obesity Surgery, vol. 15, no. 10, pp. 1463–1468, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Nishimura, I. Manabe, M. Nagasaki et al., “CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity,” Nature Medicine, vol. 15, no. 8, pp. 914–920, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. D. C. Nieman, D. A. Henson, S. L. Nehlsen-Cannarella et al., “Influence of obesity on immune function,” Journal of the American Dietetic Association, vol. 99, no. 3, pp. 294–299, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Lynch, D. O'Shea, D. C. Winter, J. Geoghegan, D. G. Doherty, and C. O'Farrelly, “Invariant NKT cells and CD1d+ cells amass in human omentum and are depleted in patients with cancer and obesity,” European Journal of Immunology, vol. 39, no. 7, pp. 1893–1901, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. L. A. Lynch, J. M. O'Connell, A. K. Kwasnik, T. J. Cawood, C. O'Farrelly, and D. B. O'Shea, “Are natural killer cells protecting the metabolically healthy obese patient?” Obesity, vol. 17, no. 3, pp. 601–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. C. K. Lo, Q. L. Lam, M. Yang et al., “Leptin signaling protects NK cells from apoptosis during development in mouse bone marrow,” Cellular and Molecular Immunology, vol. 6, no. 5, pp. 353–360, 2009. View at Publisher · View at Google Scholar
  50. S. Afshar, S. B. Kelly, K. Seymour, J. Lara, S. Woodcock, and J. C. Mathers, “The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis,” Obesity Surgery, vol. 24, no. 10, pp. 1793–1799, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. D. F. Williamson, E. Pamuk, M. Thun, D. Flanders, T. Byers, and C. Heath, “Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years,” American Journal of Epidemiology, vol. 141, no. 12, pp. 1128–1141, 1995. View at Publisher · View at Google Scholar · View at Scopus
  52. E. D. Parker and A. R. Folsom, “Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study,” International Journal of Obesity and Related Metabolic Disorders, vol. 27, no. 12, pp. 1447–1452, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. E. D. Shade, C. M. Ulrich, M. H. Wener et al., “Frequent intentional weight loss is associated with lower natural killer cell cytotoxicity in postmenopausal women: possible long-term immune effects,” Journal of the American Dietetic Association, vol. 104, no. 6, pp. 903–912, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Barone and J. R. Hebert, “Dietary fat and Natural Killer cell activity,” Medical Hypotheses, vol. 25, no. 4, pp. 223–226, 1988. View at Publisher · View at Google Scholar · View at Scopus
  55. O. Lamas, J. A. Martínez, and A. Marti, “Energy restriction restores the impaired immune response in overweight (cafeteria) rats,” Journal of Nutritional Biochemistry, vol. 15, no. 7, pp. 418–425, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. E. J. Wing, R. T. Stanko, A. Winkelstein, and S. A. Adibi, “Fasting-enhanced immune effector mechanisms in obese subjects,” The American Journal of Medicine, vol. 75, no. 1, pp. 91–96, 1983. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Coca, J. Perez-Piqueras, D. Martinez et al., “The prognostic significance of intratumoral natural killer cells in patients with colerectal carcinoma,” Cancer, vol. 79, no. 12, pp. 2320–2328, 1997. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Wang, J. Sun, C. Ma et al., “Reduced expression of galectin-9 contributes to a poor outcome in colon cancer by inhibiting NK cell chemotaxis partially through the Rho/ROCK1 signaling pathway,” PLoS ONE, vol. 11, no. 3, Article ID e0152599, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Mori, H. Sakurai, M.-K. Choo et al., “Severe pulmonary metastasis in obese and diabetic mice,” International Journal of Cancer, vol. 119, no. 12, pp. 2760–2767, 2006. View at Publisher · View at Google Scholar · View at Scopus